New hope for pancreatic cancer: experimental combo enters human testing
NCT ID NCT04104672
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 28 times
Summary
This early-stage study tests a new drug called AB680 combined with three other medications (zimberelimab, nab-paclitaxel, and gemcitabine) in people with advanced pancreatic cancer that has not been treated before. The main goals are to check safety and find the right dose. About 196 participants will take part. This is not a cure but aims to control the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Los Angeles, California, 90025, United States
-
Research Site
Santa Monica, California, 90404, United States
-
Research Site
St Louis, Missouri, 63110, United States
-
Research Site
New York, New York, 10016, United States
-
Research Site
New York, New York, 10032, United States
-
Research Site
New York, New York, 10065, United States
-
Research Site
Oklahoma City, Oklahoma, 73104, United States
-
Research Site
Philadelphia, Pennsylvania, 19104, United States
-
Research Site
Pittsburgh, Pennsylvania, 15232, United States
-
Research Site
Nashville, Tennessee, 37203, United States
-
Research Site
Houston, Texas, 77030, United States
-
Research Site
San Antonio, Texas, 78229, United States
-
Research Site
Madison, Wisconsin, 53792, United States
Conditions
Explore the condition pages connected to this study.